WELCOME TO THE TURKISH MYELOMA
STUDY GROUP WEBSITE

Access the latest news and clinical trials on Multiple Myeloma from a single point.


EMN Visual
Multiple Myeloma Joint Education Program
EHA Banner
COMY Banner
7th European Myeloma Network Meeting
8th Translational Research Conference Multiple Myeloma
EBMT 2026
IMS Upcoming Meetings
Onco Summit
European Multiple Myeloma Academy
European Myeloma Network Visual

Announcements

Latest Announcements from the Turkish Myeloma Study Group

Webinar

Post-EHA 2026 Multiple Myeloma Highlights Webinar Series

On June 30, 2026, the webinar series organized by VJHemOnc will discuss the most recent EHA 2026 data in the fields of Multiple Myeloma and AL Amyloidosis with international experts. Key topics including CAR-T cell therapies, T-cell engagers, novel therapeutic agents, and smoldering myeloma will be addressed.

Download Agenda (PDF)
Turkish Myeloma Study Group Diagnosis and Treatment Guidelines

Turkish Myeloma Study Group

Updated Diagnosis and Treatment Guidelines

You can digitally access our up-to-date guidelines that guide our national treatment algorithms, optimized in light of the latest scientific developments, international guidelines, and clinical experience in the field of Multiple Myeloma. This comprehensive resource, which our physicians can use as a reference in diagnosis, treatment, and patient follow-up processes, can be downloaded from the link below.

Download Guidelines as PDF
AL Amyloidosis Diagnosis and Treatment Guidelines

AL Amyloidosis Diagnosis and Treatment Guidelines

AL Amyloidosis is a significant disease caused by the accumulation of abnormal proteins produced by plasma cells in the heart, kidneys, nervous system, and other organs. This guideline has been prepared by the Turkish Society of Hematology to facilitate early diagnosis of the disease, plan appropriate treatment, and improve patients' quality of life. It covers important topics such as new diagnostic approaches, treatment options, maintenance therapy, management of relapse, and organ transplantation. We hope it will serve as a valuable resource for your patients and follow-up processes.

Download Guidelines (DOCX)
TMCG Mobile Application Interface

Patient Diagnosis and Treatment Application

MmGTr Mobile Application

Our official mobile application MmGTr (Myeloma Group Türkiye) has been launched to optimize Multiple Myeloma patient follow-up and clinical processes. Designed to facilitate the clinical practice of our physicians, the application includes a real-time data entry module called "Add New Patient", a "My Existing Patients" area that allows you to manage your cases from a single center, and a comprehensive "Library" guide providing quick access to current academic resources. Download our application from the appropriate app store for your platform to accelerate your clinical studies and patient management processes on your mobile devices.

Download Links: